CMC Solutions

CMC Solutions that Advance Biologics Development

CMC solutions for your success.

Developing biotechnology products requires the need to balance cost, time, and probability of success. As your partner, we’ll provide strategic advice and solutions designed to ensure success across the full product lifecycle.

Helping you navigate the complex demands of product development

Your Alira Health team has in-depth understanding of the technical and regulatory challenges of drug development. Led by Steven Chamow, PhD, an industry leading expert with over 30 years of experience, our team of subject matter experts will work closely with you to guide you through the most demanding projects.

Meet our team
The Alira Health team is essential when it comes to delivering our products on time with the right quality.
Peter Frank
Head of CMC, ITB-MED

Why choose Alira Health's CMC Solutions?

For over a decade, our dedicated CMC solutions team has supported our clients from engagement to launch. With many years of industry experience, we provide clients with the following:

  • Comprehensive, integrated CMC services with a flexible service model that grows with your programs
  • Knowledgeable industry experts who deliver scalable, actionable insights
  • A focus on risk management that is designed to ensure completion of your technical goals
  • Commitment to client advocacy with vendors to drive holistic solutions tailored to your business needs and goals

Partnering for Successful CMC Solutions

Whether you need to understand which asset best aligns with your long-term strategy, which new market or therapeutic area to explore, or how to expand into another sector, we are ready to help you lead the way.

Contact us
Steve Chamow
Steve Chamow
Senior Vice President, CMC
Integrity, competence, and collaboration are the foundation of our partnerships. This has allowed us—for over a decade—to help clients succeed in bringing new medicines to market.

CMC Solutions - Related News

Publications September 16, 2022
Considerations for Analyzing and Interpreting Data from Biometric Monitoring Technologies in Clinical Trials
The rise of technology in clinical research allows us to capture meaningful aspects of health in clinical study participants.
Biometrics Clinical eCOA
Publications September 7, 2022
The Promise and Reality of Decentralized and Hybrid Clinical Trials in Europe Today
To understand the challenges related to hybrid and decentralized trials and ways to overcome them, we spoke with Dr. Hervé Solatges, Product Management, Evidence, and Innovation (DCT(...)
Clinical Decentralized Clinical Trials Hybrid Clinical Trials
Publications September 5, 2022
Taking In-Licensed Biologics to Market: Challenges, Complexities, and Ways to Overcome Them
Taking a biologic through drug development to market is highly complex and filled with challenges. To understand these challenges, their implications and how to overcome them, we spoke(...)
Biologics Clinical Drug Development
Events August 10, 2022
DPHARM
We are pleased to announce that we will be sponsoring and attending DPHARM, a unique event focused on the latest innovations that modernize clinical trials.
Clinical Decentralized Clinical Trials DPHARM Patient Centric
Publications August 2, 2022
GMP Manufacturing and IND-Enabling Studies of a Recombinant Hyperimmune Globulin Targeting SARS-CoV-2
The last two years have brought forward tremendous advances in the development of prophylactic and therapeutic approaches for the treatment of SARS-CoV-2 infections.
Clinical CMC Vaccines
Multimedia May 19, 2022
Fireside Chat Replay: Latest Developments in Oncology Supportive Care
In this fireside chat, we sit down with two medical experts in oncology and discuss some of the fascinating developments that are happening in the oncology supportive care field.
Clinical
Events May 19, 2022
DIA 2022 Global Annual Meeting
We are pleased to announce that we will be joining DIA 2022 Global Annual Meeting as exhibitors and delegates.
Biometrics Clinical Life Sciences Regulatory
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.